Chemoinformaics analysis of (+)-S-(1-propenyl)-L-cysteine sulfoxide (PRENCSO)
| Molecular Weight | 177.225 | nRot | 4 |
| Heavy Atom Molecular Weight | 166.137 | nRig | 2 |
| Exact Molecular Weight | 177.046 | nRing | 0 |
| Solubility: LogS | -0.173 | nHRing | 0 |
| Solubility: LogP | -2.374 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 23.7607 |
| nHD | 1 | BPOL | 16.1893 |
| QED | 0.522 |
| Synth | 5.847 |
| Natural Product Likeliness | 0.447 |
| NR-PPAR-gamma | 0.02 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.109 |
| HIA | 0.078 |
| CACO-2 | -5.325 |
| MDCK | 0.00308684 |
| BBB | 0.649 |
| PPB | 0.0733145 |
| VDSS | 0.615 |
| FU | 0.903403 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.059 |
| CYP2c19-inh | 0.024 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.016 |
| CYP2c9-sub | 0.669 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.161 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.016 |
| CL | 2.265 |
| T12 | 0.895 |
| hERG | 0.008 |
| Ames | 0.669 |
| ROA | 0.416 |
| SkinSen | 0.474 |
| Carcinogencity | 0.682 |
| EI | 0.093 |
| Respiratory | 0.477 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.919566 |